Stock Events

Stock Events

Elekta AB 

$6
67
+$0+0% Tuesday 14:19

Statistics

Day High
6
Day Low
6
52W High
6.83
52W Low
4.48
Volume
100
Avg. Volume
-
Mkt Cap
2.21B
P/E Ratio
-
Dividend Yield
4.32%
Dividend
0.26

Upcoming

8
SEP
Dividend Ex
Estimated
 
11
SEP
Dividend Payment
Estimated
 
8
MAR 27
Dividend Ex
Estimated
 
11
MAR 27
Dividend Payment
Estimated
 
8
SEP 27
Dividend Ex
Estimated
 

Dividends

4.32%Dividend Yield
Mar 26
$0.13
Sep 25
$0.13
Mar 25
$0.12
Sep 24
$0.12
Mar 24
$0.12
10Y Growth
24.41%
5Y Growth
15.45%
3Y Growth
4.93%
1Y Growth
4.77%

Earnings

28MayExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
0.03
0.07
0.11
0.15
Expected EPS
0.1510626975
Actual EPS
N/A

Financials

1.31%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
3.69BRevenue
48.34MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow EKTAF. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Medtronic
MDT
Mkt Cap102.71B
Medtronic competes with Elekta in the neurosurgical market, offering products for brain surgeries and pain management that overlap with Elekta's Gamma Knife radiosurgery systems.
Intuitive Surgical
ISRG
Mkt Cap162.13B
Intuitive Surgical competes in the surgical space with robotic systems that, while not directly radiation therapy, offer alternative treatments for conditions Elekta's products also address.
Boston Scientific
BSX
Mkt Cap83.97B
Boston Scientific competes in the medical device market, particularly in neuromodulation, where its products can be seen as alternatives to Elekta's for certain conditions.
Smith & Nephew
SNN
Mkt Cap13.3B
Smith & Nephew competes in the advanced wound management and surgical devices market, indirectly competing with Elekta's offerings in surgical and oncology care.
Zimmer Biomet
ZBH
Mkt Cap16.05B
Zimmer Biomet competes in the musculoskeletal healthcare market, including surgical solutions that can indirectly compete with Elekta's products for certain therapeutic and diagnostic applications.
Stryker
SYK
Mkt Cap112.88B
Stryker competes across several medical device markets, including neurotechnology and spine, where its products can compete with Elekta's neurosurgical and radiosurgery offerings.
Globus Medical
GMED
Mkt Cap12.39B
Globus Medical competes in the spine and neurosurgery markets with products that can be alternatives to Elekta's solutions for spinal and brain conditions.
Abbvie
ABBV
Mkt Cap365.43B
AbbVie, through its acquisition of Allergan, competes in the neuroscience space, offering pharmaceutical alternatives to Elekta's device-based treatments for neurological conditions.
Johnson & Johnson
JNJ
Mkt Cap546.9B
Johnson & Johnson, through its medical devices division, competes in several areas including surgery and oncology, offering products that can be seen as alternatives to Elekta's radiation therapy and neurosurgery devices.

About

There is no Profile data available for EJXB.SG.
Show more...
CEO
Dr. Laurent Leksell
Employees
4541
Country
Sweden
ISIN
SE0000163628

Listings

MX
MX
EKTABN.MX
MI
IT
1EKTA.MI
STU
DE
EJXB.STU
MU
DE
EJX.MU

0 Comments

Share your thoughts

FAQ

What is Elekta AB stock price today?▼
The current price of EKTAF is $6 USD — it has increased by +0% in the past 24 hours. Watch Elekta AB stock price performance more closely on the chart.
What is Elekta AB stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Elekta AB stocks are traded under the ticker EKTAF.
What is Elekta AB market cap?▼
Today Elekta AB has the market capitalization of 2.21B
When is the next Elekta AB earnings date?▼
Elekta AB is going to release the next earnings report on May 28, 2026.
What were Elekta AB earnings last quarter?▼
EKTAF earnings for the last quarter are 0.1 USD per share, whereas the estimation was 0.05 USD resulting in a +80.13% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Elekta AB revenue for the last year?▼
Elekta AB revenue for the last year amounts to 3.69B USD.
What is Elekta AB net income for the last year?▼
EKTAF net income for the last year is 48.34M USD.
Does Elekta AB pay dividends?▼
Yes, EKTAF dividends are paid semi-annual. The last dividend per share was 0.13 USD. As of today, Dividend Yield (FWD)% is 4.32%.
How many employees does Elekta AB have?▼
As of May 06, 2026, the company has 4,541 employees.
In which sector is Elekta AB located?▼
Elekta AB operates in the Health & Wellness sector.
When did Elekta AB complete a stock split?▼
The last stock split for Elekta AB was on September 12, 2012 with a ratio of 4:1.
Where is Elekta AB headquartered?▼
Elekta AB is headquartered in Stockholm, Sweden.